Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
Dr. Nicholas James
Advertisement
James is a professor of Prostate and Bladder Cancer Research, as well as a group leader in Prostate and Bladder Cancer Research, at The Institute of Cancer Research and The Royal Marsden Hospital, located in London, England.
Articles by Dr. Nicholas James
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top Breast Cancer Stories to Know as Breast Cancer Awareness Month Kicks Off
2
Top GI News From September: GIST, Pancreatic and Colorectal Cancers
3
What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?
4
Pivekimab Sunirine Application Submitted to FDA for Rare Blood Cancer
5
